BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ)
$8.98 -0.26 (-2.8139%)
Analysed BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) News Sources
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02-07-2026
yahoo.com
Why Did CRNX, D, BCRX Stocks Surge To 52-Week Highs Today?
08-07-2026
stocktwits.com
VKTX Vs BCRX: Which Biotech Takeover Favorite Offers More Upside After Vertex’s $10B CRNX Deal?
08-07-2026
stocktwits.com
BioCryst (BCRX) Surges 8.1%: Is This an Indication of Further Gains?
08-07-2026
yahoo.com
BioCryst Pharmaceuticals (BCRX) Ends Internal Discovery And Closes Birmingham Facility
09-07-2026
yahoo.com
Why Did PENG, ANET, BCRX Shares Surge To 52-Week Highs?
09-07-2026
stocktwits.com
BioCryst (BCRX) Stock Looks Below Fair Value As Caution Lingers
09-07-2026
yahoo.com
Wall Street Analysts Think BioCryst (BCRX) Could Surge 117.96%: Read This Before Placing a Bet
14-07-2026
yahoo.com
BioCryst Appoints David W. Jenkins as Chief Scientific Officer
15-07-2026
yahoo.com
BioCryst to Report Second Quarter 2026 Financial Results on August 5
22-07-2026
yahoo.com
What is the current price of BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ)?
The current price of BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) is $8.98.
BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) since the previous trading day is $-0.26.
BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) since the previous trading day is -2.8139%.
What is the most recent average sentiment score for BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ)?
The most recent average sentiment score for BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) is 57 out of 100.
What is the most recent average sentiment for BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ)?
The most recent sentiment for BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) is .
SEC-8K** Filing Available For BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.